Liminal Biosciences

Liminal BioSciences is an international biopharmaceutical company specializing in the exploration, advancement, and commercialization of innovative small molecule compounds for respiratory, hepatic, and renal conditions. Our primary focus lies in devising remedies for uncommon and neglected ailments. Liminal BioSciences conducts operations through its interconnected centers of excellence located in Laval, Quebec, Canada, Cambridge, UK, and Rockville, Maryland, USA. Our ordinary shares are publicly traded on the Nasdaq Global Market and the Toronto Stock Exchange (Symbol: LMNL).